ERIVAN BIO, LLC

ALACHUA, FL · Founded 2018 · Biotech · Private

Engineered exosomes for health and wellness applications

Claim this profile

Follows are private to you and power your alerts

Updated · erivanbio.com

Sector
Biotech
Headquarters
ALACHUA, FL
Founded
2018
Latest Form D
Aug 2022
Total capital
$500K
Federal grants
$250K
1 award · 2024
Rank in peer group#214 of 392
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
$250K
1 award · Defense
Rank in Biotech#285 of 4373
Granted patents
0
2 pending

Capital timeline

2024FEDERAL ↑EQUITY ↓Cumulative $500K$250K$250K
2024FEDERAL ↑EQUITY ↓Cumulative $500K$250K$250K

Latest events

  • Federal contractDefense · Dha STTR Ph I Proposal H23C-002-0046 Title Novel Scalable Loading Of Antibiotics In Exosomes For Bacterial Wound Infection Prevention Log Number 23000582$250K
  • Federal grantDefense · Phase I · Dha STTR Ph I Proposal H23C-002-0046 Title Novel Scalable Loading Of Antibiotics In Exosomes For Bacterial Wound Infection Prevention Log Number 23000582$250K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

1 record has no date or no amount, so it isn’t placed on the timeline.

Standing among 392 peers

Line = median

Biotech · Molecule

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Nasser Nassiri KoopaeiExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 2
  • PendingTopical Exosome Compositions and Associated MethodsUSPTOApplication 16936090
  • PendingTopical Exosome Compositions And Associated MethodsUSPTOApplication PCTUS2020043102

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .